DE60306517D1 - Verfahren zum nachweis und zur quantifizierung von -aus soliden tumoren abstammenden- zirkulierenden tumorzellen - Google Patents

Verfahren zum nachweis und zur quantifizierung von -aus soliden tumoren abstammenden- zirkulierenden tumorzellen

Info

Publication number
DE60306517D1
DE60306517D1 DE60306517T DE60306517T DE60306517D1 DE 60306517 D1 DE60306517 D1 DE 60306517D1 DE 60306517 T DE60306517 T DE 60306517T DE 60306517 T DE60306517 T DE 60306517T DE 60306517 D1 DE60306517 D1 DE 60306517D1
Authority
DE
Germany
Prior art keywords
cells
tumour
tumor cells
culture surface
tumour markers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60306517T
Other languages
English (en)
Other versions
DE60306517T2 (de
Inventor
Jean-Pierre Vendrell
Catherine Panabieres
Genevieve Choquet-Kastylevsky
Michel Jolivet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomerieux SA
Centre Hospitalier Universitaire de Montpellier CHUM
Original Assignee
Biomerieux SA
Centre Hospitalier Universitaire de Montpellier CHUM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomerieux SA, Centre Hospitalier Universitaire de Montpellier CHUM filed Critical Biomerieux SA
Application granted granted Critical
Publication of DE60306517D1 publication Critical patent/DE60306517D1/de
Publication of DE60306517T2 publication Critical patent/DE60306517T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE60306517T 2002-03-13 2003-03-13 Verfahren zum nachweis und zur quantifizierung von -aus soliden tumoren abstammenden- zirkulierenden tumorzellen Expired - Lifetime DE60306517T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0203136 2002-03-13
FR0203136 2002-03-13
PCT/FR2003/000806 WO2003076942A2 (fr) 2002-03-13 2003-03-13 Quantification de cellules tumorales circulantes issues de cancers solides

Publications (2)

Publication Number Publication Date
DE60306517D1 true DE60306517D1 (de) 2006-08-10
DE60306517T2 DE60306517T2 (de) 2007-01-04

Family

ID=27799043

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60306517T Expired - Lifetime DE60306517T2 (de) 2002-03-13 2003-03-13 Verfahren zum nachweis und zur quantifizierung von -aus soliden tumoren abstammenden- zirkulierenden tumorzellen

Country Status (8)

Country Link
US (1) US20050079557A1 (de)
EP (1) EP1506407B1 (de)
JP (1) JP4256265B2 (de)
AT (1) ATE331958T1 (de)
AU (1) AU2003242815A1 (de)
DE (1) DE60306517T2 (de)
ES (1) ES2268387T3 (de)
WO (1) WO2003076942A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2846426B1 (fr) 2002-10-28 2004-12-10 Bio Merieux Procede de dosage du ngf pour le diagnostic in vitro du cancer du sein et utilisation en therapie
US7666583B2 (en) * 2004-02-19 2010-02-23 Yale University Identification of cancer protein biomarkers using proteomic techniques
CA2600225C (en) * 2005-03-14 2016-06-28 Immunivest Corporation A method for predicting progression free and overall survival at each follow-up time point during therapy of metastatic breast cancer patients using circulating tumor cells
FR2896881B1 (fr) 2006-01-31 2008-04-18 Biomerieux Sa Procede de dosage du prongf pour le diagnostic in vitro du cancer du sein et utilisation du prongf en therapie
EP2007904A4 (de) * 2006-03-13 2009-06-10 Veridex Llc Fortpflanzung von primärzellen
WO2008029251A2 (en) * 2006-09-07 2008-03-13 Universitatsklinikum Hamburg-Eppendorf Method for the detection of cancerous epithelial cells using released cytokeratins as markers for said cells
GB0815675D0 (en) 2008-08-28 2008-10-08 Mabtech Ab Antibody secreting cell elispot
DK2591363T3 (en) * 2010-07-07 2017-12-11 Univ Michigan Regents DIAGNOSIS AND TREATMENT OF BREAST CANCER
JP5804634B2 (ja) * 2011-10-07 2015-11-04 久和 内山 植物栽培装置
AU2014209218B2 (en) 2013-01-25 2018-06-07 Xcell Biosciences, Inc. Methods, compositions, kits, and systems for selective enrichment of target cells
FR3001805B1 (fr) 2013-02-01 2015-02-20 Biomerieux Sa Procede de detection d'un cancer colorectal
CN106244553A (zh) * 2015-10-22 2016-12-21 厦门人瑞生物医药科技有限公司 循环肿瘤细胞的分离和检测方法
FR3050212B1 (fr) 2016-04-15 2020-09-25 Chu Montpellier Procede de detection et/ou de caracterisation de cellules tumorales et appareil associe
JP2019158777A (ja) * 2018-03-16 2019-09-19 東ソー株式会社 腫瘍マーカーならびに腫瘍細胞を夾雑細胞と区別して回収および検出する方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL121659A (en) * 1996-10-25 2000-07-16 Bayer Ag Method for determining CPSA in a blood sample
US6316213B1 (en) * 1997-03-19 2001-11-13 The Board Of Trustees Of The University Of Arkansas Methods for the early diagnosis of ovarian, breast and lung cancer
DE69941689D1 (de) * 1998-02-12 2010-01-07 Univ Texas Verfahren und reagenzien zur raschen und effizienten isolierung zirkulierender krebszellen

Also Published As

Publication number Publication date
ES2268387T3 (es) 2007-03-16
JP4256265B2 (ja) 2009-04-22
AU2003242815A1 (en) 2003-09-22
DE60306517T2 (de) 2007-01-04
JP2005527793A (ja) 2005-09-15
US20050079557A1 (en) 2005-04-14
EP1506407A2 (de) 2005-02-16
ATE331958T1 (de) 2006-07-15
AU2003242815A8 (en) 2003-09-22
EP1506407B1 (de) 2006-06-28
WO2003076942A2 (fr) 2003-09-18
WO2003076942A3 (fr) 2004-04-08

Similar Documents

Publication Publication Date Title
Mizutani et al. Expression of somatostatin receptor (SSTR) subtypes (SSTR-1, 2A, 3, 4 and 5) in neuroendocrine tumors using real-time RT-PCR method and immunohistochemistry
Park et al. Comprehensive analysis of HER2 expression and gene amplification in gastric cancers using immunohistochemistry and in situ hybridization: which scoring system should we use?
Schnitt Breast cancer in the 21st century: neu opportunities and neu challenges
DE60306517D1 (de) Verfahren zum nachweis und zur quantifizierung von -aus soliden tumoren abstammenden- zirkulierenden tumorzellen
CA2699702A1 (en) Cancer marker and therapeutic target
JP2009115817A (ja) 膠芽腫の進行に関連する経路を試験するための方法及び材料
Maxwell et al. A practical method to determine the site of unknown primary in metastatic neuroendocrine tumors
AU2010291710B2 (en) Methods and compositions for detection of lethal cell and uses thereof
EP1759010A2 (de) Biomarker und verfahren zur bestimmung der empfindlichkeit gegenüber modulatoren des egf(epidermal growth factor)-rezeptors
Pillai et al. Identifying biomarkers of breast cancer micrometastatic disease in bone marrow using a patient-derived xenograft mouse model
Song et al. Combined detection of HER2, Ki67, and GSTP1 genes on the diagnosis and prognosis of breast cancer
Xu et al. Atrophic dermatofibrosarcoma protuberans: a clinicopathological study of 16 cases
ATE545867T1 (de) I-plastin-testverfahren zur in-vitro-diagnose von kolorektalkarzinom
ATE419533T1 (de) Verfahren/präparat zur erkennung von pankreaskrebs
JP2008524230A5 (de)
WO2009019366A3 (fr) Procede de dosage de l'aminoacylase 1 pour le diagnostic in vitro du cancer colorectal
Wang et al. Expression of STK15 mRNA in hepatocellular carcinoma and its prognostic significance
Reiter et al. Mutagen sensitivity and DNA repair of the EGFR gene in oropharyngeal cancer
WO2003068268A3 (en) Treatment, diagnosis and imaging of disease
WO2014185528A1 (ja) Ｔｋ１タンパク質の発現が亢進した結腸直腸癌患者に対する治療効果予測方法
KR101238196B1 (ko) 대장암의 간 전이 진단용 조성물 및 그 용도
Cherciu et al. Targeted Confocal Laser Endomicroscopy (CLE) for the Assessment of Putative Cancer Stem Cell Markers in Colorectal cancer-A Pilot Study
JP7246731B2 (ja) 膵癌の予後マーカー、膵癌の予後診断キット及び膵癌の予後を予測するための方法
WO2008091994A3 (en) Mage-11 as a marker for endometrial receptivity to embryo transplantation and a marker and therapeutic target in castration-recurrent prostate cancer
Kripp et al. Prognostic Impact of mRNA Expression Levels of HER1–4 (ERBB1–4) in Patients with Locally Advanced Rectal Cancer

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: WITTE, WELLER & PARTNER, 70178 STUTTGART